The fact that HIF1α protein levels and its target genes were elevated in the pre-tumor stage (6 months; Fig. 4e) implies that these metabolic changes fuel and drive HCC development in DEN-treated WwoxΔHep mice. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.